Effect of advanced glycation end product intake on inflammation and aging: A systematic review

Nutrition Reviews

Volumn 72, Issue 10, 2014, Pages 638-650

  Van Puyvelde, Katrien ^a,b   Mets, Tony ^a,b   Njemini, Rose ^a   Beyer, Ingo ^a,b   Bautmans, Ivan ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Advanced glycation end products; Age related chronic disease; Aging; Inflammation

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

AGING; ARTICLE; CARBOHYDRATE INTAKE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIETARY INTAKE; HUMAN; INFLAMMATION; INTERVENTION STUDY; MUSCLE ATROPHY; NONHUMAN; NUTRITIONAL ASSESSMENT; OBSERVATIONAL STUDY; SKELETAL MUSCLE; SYSTEMATIC REVIEW; ANIMAL; COOKING; DIET; METABOLISM; MUSCLE WEAKNESS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGING; ANIMALS; COOKING; DIET; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; MUSCLE WEAKNESS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84913606113     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12141     Document Type: Article

References (59)

1. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39:687-699.
2. Uribarri J, Cai W, Peppa M, etal. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007;62:427-433.
3. Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65:963-975.
4. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res. 2001;56:1-21.
5. Luevano-Contreras C, Chapman-Novakofski K. Dietary advanced glycation end products and aging. Nutrients. 2010;2:1247-1265.
6. Ahmed N. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67:3-21.
7. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA. 2002;288:2579-2588.
8. Bierhaus A, Humpert PM, Morcos M, etal. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med. 2005;83:876-886.
9. Chuah YK, Basir R, Talib H, etal. Receptor for advanced glycation end products and its involvement in inflammatory diseases. Int J Inflam. 2013;2013:403-460.
10. Schmidt AM, Yan SD, Yan SF, etal. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108:949-955.
11. Lukic IK, Humpert PM, Nawroth PP, etal. The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy. Ann N Y Acad Sci. 2008;1126:76-80.
12. Lin L, Park S, Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci. 2009;14:1403-1413.
13. shc-dependent FKHRL1 phosphorylation. Am J Physiol Cell Physiol. 2008;294:C145-C152.
14. Cai W, He JC, Zhu L, etal. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci USA. 2006;103:13801-13806.
15. Lu C, He JC, Cai W, etal. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci USA. 2004;101:11767-11772.
16. Verzijl N, DeGroot J, Oldehinkel E, etal. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J. 2000;350(Pt 2):381-387.
17. Haus JM, Carrithers JA, Trappe SW, etal. Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. J Appl Physiol. 2007;103:2068-2076.
18. Koschinsky T, He CJ, Mitsuhashi T, etal. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA. 1997;94:6474-6479.
19. Geissler S, Hellwig M, Zwarg M, etal. Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1. J Agric Food Chem. 2010;58:2543-2547.
20. Negrean M, Stirban A, Stratmann B, etal. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2007;85:1236-1243.
21. Peppa M, Uribarri J, Cai W, etal. Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis. 2004;43:690-695.
22. Vlassara H, Cai W, Crandall J, etal. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA. 2002;99:15596-15601.
23. Vlassara H, Cai W, Goodman S, etal. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab. 2009;94:4483-4491.
24. National Institute for Health and Care Excellence. Methodology checklist: randomised controlled trials. Available at: http://publications.nice.org.uk/the-guidelines-manual-appendices-bi-pmg6b/appendix-c-methodology-checklist-randomised-controlled-trials. Published November 30, 2012. Accessed August 18, 2014.
25. von Elm E, Altman DG, Egger M, etal. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344-349.
26. Cai W, He JC, Zhu L, etal. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol. 2007;170:1893-1902.
27. Cassese A, Esposito I, Fiory F, etal. In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J Biol Chem. 2008;283:36088-36099.
28. Cai W, He JC, Zhu L, etal. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol. 2008;173:327-336.
29. Tikellis C, Thomas MC, Harcourt BE, etal. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab. 2008;295:E323-E330.
30. Sato T, Wu X, Shimogaito N, etal. Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys. Eur J Nutr. 2009;48:6-11.
31. Sebeková K, Krajcoviová-Kudlácková M, Schinzel R, etal. Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a Western mixed diet. Eur J Nutr. 2001;40:275-281.
32. Schiekofer S, Franke S, Andrassy M, etal. Postprandial mononuclear NF-κB activation is independent of the AGE-content of a single meal. Exp Clin Endocrinol Diabetes. 2006;114:160-167.
33. de la Maza MP, Bravo A, Leiva L, etal. Fluorescent serum and urinary advanced glycoxidation end-products in non-diabetic subjects. Biol Res. 2007;40:203-212.
34. Sjögren P, Basta G, de Caterina R, etal. Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product Nε-carboxymethyl-lysine in healthy Swedish men. Atherosclerosis. 2007;195:e168-e175.
35. Piroddi M, Palazzetti I, Quintaliani G, etal. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study. J Ren Nutr. 2011;21:329-339.
36. Jara N, Leal MJ, Bunout D, etal. Dietary intake increases serum levels of carboxymethil-lysine (CML) in diabetic patients. Nutr Hosp. 2012;27:1272-1278.
37. Luévano-Contreras C, Garay-Sevilla ME, Wrobel K, etal. Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus. J Clin Biochem Nutr. 2013;52:22-26.
38. Iwashige K, Kouda K, Kouda M, etal. Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis. J Physiol Anthropol Appl Human Sci. 2004;23:19-24.
39. Teillet L, Verbeke P, Gouraud S, etal. Food restriction prevents advanced glycation end product accumulation and retards kidney aging in lean rats. J Am Soc Nephrol. 2000;11:1488-1497.
40. Hofmann SM, Dong HJ, Li Z, etal. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes. 2002;51:2082-2089.
41. Zheng F, He C, Cai W, etal. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab Res Rev. 2002;18:224-237.
42. Sandu O, Song K, Cai W, etal. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes. 2005;54:2314-2319.
43. Sebekova K, Hofmann T, Boor P, etal. Renal effects of oral Maillard reaction product load in the form of bread crusts in healthy and subtotally nephrectomized rats. Ann N Y Acad Sci. 2005;1043:482-491.
44. Sebekova K, Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects - PRO. Mol Nutr Food Res. 2007;51:1079-1084.
45. Goldberg T, Cai W, Peppa M, etal. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc. 2004;104:1287-1291.
46. Ames JM. Determination of Nε-(carboxymethyl) lysine in foods and related systems. Ann N Y Acad Sci. 2008;1126:20-24.
47. Delatour T, Hegele J, Parisod V, etal. Analysis of advanced glycation endproducts in dairy products by isotope dilution liquid chromatography-electrospray tandem mass spectrometry. The particular case of carboxymethyllysine. J Chromatogr A. 2009;1216:2371-2381.
48. Assar SH, Moloney C, Lima M, etal. Determination of Nε-(carboxymethyl) lysine in food systems by ultra performance liquid chromatography-mass spectrometry. Amino Acids. 2009;36:317-326.
49. Peppa M, Uribarri J, Vlassara H. Aging and glycoxidant stress. Hormones (Athens). 2008;7:123-132.
50. Thompson FE, Subar AF. Dietary assessment methodology. In: Coulston AM, Boushey CJ, Ferruzzi MG, eds. Nutrition in the Prevention and Treatment of Disease. San Diego: Elsevier Academic Press; 2013:5-46.
51. Uribarri J, Woodruff S, Goodman S, etal. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110:911-916.e12.
52. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-991S.
53. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care. 2012;15:12-22.
54. Payne GW. Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation. 2006;13:343-352.
55. Semba RD, Bandinelli S, Sun K, etal. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study. Eur J Appl Physiol. 2010;108:191-195.
56. Dalal M, Ferrucci L, Sun K, etal. Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci. 2009;64:132-137.
57. Grasa J, Calvo B, Delgado-Andrade C, etal. Variations in tendon stiffness due to diets with different glycotoxins affect mechanical properties in the muscle-tendon unit. Ann Biomed Eng. 2013;41:488-496.
58. de la Maza MP, Uribarri J, Olivares D, etal. Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury. Rejuvenation Res. 2008;11:1041-1048.
59. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239-247.